Source: Annual Congress 2008 - Understanding the mechanisms and the impact of severe asthma
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
C. Micheletto, F. Trevisan, S. Bertacco, M. Visconti, R. Dal Negro (Bussolengo – VR, Italy). The incidence of nasal polyps and corresponding LTE₄ levels in severe asthma. Eur Respir J 2008; 32: Suppl. 52, 2982

Member's Comments

No comment yet.

Related content which might interest you: Nasal polyps support a higher LTE4 urinary excretion in aspirin-induced asthma (AIA) Source: Eur Respir J 2004; 24: Suppl. 48, 509s Year: 2004 Basement membrane thickness, eosinophilic inflammation and urinary LTE4 in patients with nasal polyps with or without bronchial asthma Source: Annual Congress 2007 - Mechanisms of inflammation in asthma and rhinitis - from cell cultures to patients Year: 2007 Dupilumab reduces blood and nasal biomarkers of type 2 inflammation in patients with chronic rhinosinusitis with nasal polyps with and without comorbid asthma: SINUS-52 trial Source: Virtual Congress 2020 – Phenotypes of asthma and COPD Year: 2020 Clinically concomitant involvement of upper airways in patients with bronchial asthma Source: Eur Respir J 2004; 24: Suppl. 48, 510s Year: 2004 The impact of targeted therapy in children with uncontrolled allergic persistent severe asthma and nasal polyps Source: International Congress 2017 – Paediatric asthma: therapies and comorbidities Year: 2017 Eotaxins expression in nasal mucosa in patients with asthma and seasonal rhinitis Source: Annual Congress 2010 - Cell biology and immunology of lung disease Year: 2010 Differential treatment response to mepolizumab in severe eosinophilic asthma with nasal polyps Source: Virtual Congress 2020 – Monoclonal antibodies in asthma Year: 2020 Spontaneous airway obstruction masks FeNO level in patients with asthma but not COPD Source: Annual Congress 2012 - Exhaled biomarkers in airway diseases Year: 2012 Prostaglandin E2 levels are elevated in nasal lavages from asthmatic patients with allergic rhinitis Source: Eur Respir J 2003; 22: Suppl. 45, 109s Year: 2003 Impact of mepolizumab in severe asthma with nasal polyps Source: Virtual Congress 2021 – Asthma clinical trials and real-life studies Year: 2021 Increased expression of IL-19 in metaplastic epithelium of patients with chronic rhinosinusitis and nasal polyps Source: Annual Congress 2011 - Epithelial cell biology Year: 2011 The leukotriene E4 excretion following nasal aspirin challenges in patients with rhinitis and asthma assessed by two distinct methods Source: Annual Congress 2007 - Noninvasive evaluation of airway diseases Year: 2007 Aspirin significantly decreases urinary leukotriene E4 concentration in aspirin-tolerant asthma patients who show hyperleukotrienuria in stable condition Source: Annual Congress 2007 - New mechanisms in the pathogenesis of asthma and allergy Year: 2007 Serum ECP levels do not correlate with degree of bronchial hyperresponsiveness in patients with cough variant asthma Source: Eur Respir J 2005; 26: Suppl. 49, 584s Year: 2005 Neutrophilic inflammation in severe asthmatics and COPD patients with the same severity of airway obstruction Source: Eur Respir J 2002; 20: Suppl. 38, 505s Year: 2002 Aspirin-induced urticaria/angioedema without respiratory symptoms in severe asthmatics with nasal polyposis Source: Eur Respir J 2002; 20: Suppl. 38, 512s Year: 2002 Effect of mepolizumab on chronic rhinosinusitis symptoms and nasal hypersensitivity in patients with or without nasal polyps Source: Virtual Congress 2020 – Asthma management: role of biomarkers and comorbidities Year: 2020 Prolonged non specific airway hyperresponsiveness in atopic versus non atopic asthmatic children after upper respiratory tract infections Source: Annual Congress 2004 - Mechanisms and treatment of virus induced asthma exacerbations Year: 2004 Mepolizumab decreases urinary excretion of LTE4 in severe asthma Source: Virtual Congress 2020 – New insight into the pathogenesis of chronic lung diseases: asthma, COPD and others Year: 2020 Plasma surfactant protein A levels are increased in smokers but do not correlate with respiratory symptoms and airway obstruction Source: Annual Congress 2010 - COPD: phenotyping and monitoring Year: 2010